Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Everstar Medicines
Shanghai, Shanghai Shi, Chinauk.marketscreener.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Everstar Medicines is a private biotech/pharma company based in Shanghai focused on small molecule drugs for renal and autoimmune indications. Its leading assets are in Phase 3 clinical trials targeting chronic kidney failure and ulcerative colitis. The company also appears to be involved in other immune system and infectious disease areas. No published clinical results were found.
- Therapeutic areas
- Infectious DiseasesHematologyGastroenterologyNephrologyImmunology
- Modalities
- Small molecule drugmRNA-based drugs (if considering broader Everest/Everstar group context)
- Industry
- Biotech
02
Partnerships
Pfizer (for etrasimod, via group-level licensing with Everest Medicines)
Beyond the preview
Go deeper on Everstar Medicines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Everstar Medicines.